IDH3A and glioma: Isocitrate dehydrogenase (IDH) gene mutation as well as the combined loss of the short arm chromosome 1 and the long arm of chromosome 19 (i.e. co-deletion of 1p/19q) was considered as two important genome markers that could significantly predict the outcome of gliomas.